Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189371
Status:
TERMINATED
Last Update Posted:
2005-09-19
First Post:
2005-09-13
Brief Title:
Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer Cancer of the Fallopian Tube or Peritoneum
Sponsor:
AGO Study Group
Organization:
AGO Study Group
Organization Data
Organization:
AGO Study Group
Class:
OTHER
Study ID:
AGO-OVAR 27
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AGO Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None